fig3

Figure 3. Overall survival for ADAM9 expression in pan-cancers. Overall survival for ADAM9 expression in BRCA, CESC, COAD, KICH, LGG, LIHC, MESO, PAAD, and UVM, respectively. The P < 0.05 was considered statistically significant. BRCA: Breast invasive carcinoma; CESC: cervical squamous cell carcinoma; COAD: colon adenocarcinoma; KICH: kidney chromophobe; LGG: brain lower grade glioma; LIHC: liver hepatocellular carcinoma; MESO: mesothelioma; PAAD: pancreatic adenocarcinoma; UVM: uveal melanoma.